Liver cell transplantation could potentially be used to treat liver failure and liver-based metabolic diseases. Unfortunately, the number of human livers available for hepatocyte isolation and transplantation is limited by competition for use in whole organ transplantation. A potential alternative to the transplantation of primary hepatocytes would be to use a clonal cell line, which would provide the advantages of availability, uniformity and sterility. Such cells could be grown in unlimited number and at far less cost compared to isolated primary hepatocytes. We hypothesize that human hepatocytes can be conditionally immortalized and engineered to be safe for transplantation in the treatment of liver diseases. Rat hepatocyte cell lines have been generated that are capable of reversible immortalization by site-specific excision of an introduced SV40 T antigen using the loxP/Cre system. Such reversibly immortalized hepatocytes can correct liver function in animal models of acute and chronic liver failure and liver-based metabolic diseases. This proposal will assess whether reversibly immortalized human hepatocytes can be generated that can successfully integrate into the liver parenchyma of Rag2-/- mice following transplantation through the portal circulation. Studies will also examine whether reversibly immortalized human hepatocytes can function to correct the physiologic abnormalities associated with chronic liver decompensation in cirrhotic rats. In order to avoid the need for viral gene transfer technologies, we will also determine whether loxP/Cre generated reversibly immortalized human hepatocytes can be induced to undergo recombination using a TAT-Cre fusion protein. Finally, this proposal will evaluate the tumorigenic potential of loxP/Cre generated human hepatocytes. Evidence of alterations in tumor suppressor mechanisms will be assessed and transformation assays will be used to directly measure the tumorigenic potential of pre- and post-excision immortalized human hepatocytes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK048794-07S1
Application #
6800676
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Doo, Edward
Project Start
1996-08-01
Project End
2006-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
7
Fiscal Year
2003
Total Cost
$36,750
Indirect Cost
Name
University of Nebraska Medical Center
Department
Surgery
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Nishikawa, Taichiro; Bell, Aaron; Brooks, Jenna M et al. (2015) Resetting the transcription factor network reverses terminal chronic hepatic failure. J Clin Invest 125:1533-44
Chen, Yong; Li, Yanfeng; Wang, Xia et al. (2015) Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes. Stem Cell Reports 5:22-30
Hansel, Marc C; Gramignoli, Roberto; Blake, William et al. (2014) Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions. Cell Transplant 23:27-38
Fox, Ira J; Daley, George Q; Goldman, Steven A et al. (2014) Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science 345:1247391
Yannam, Govardhana Rao; Han, Bing; Setoyama, Kentaro et al. (2014) A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury. Int J Radiat Oncol Biol Phys 88:404-411
Bhatia, Sangeeta N; Underhill, Gregory H; Zaret, Kenneth S et al. (2014) Cell and tissue engineering for liver disease. Sci Transl Med 6:245sr2
Nishikawa, Taichiro; Bellance, Nadège; Damm, Aaron et al. (2014) A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol 60:1203-11
Fox, Ira J; Duncan, Stephen A (2013) Engineering liver tissue from induced pluripotent stem cells: a first step in generating new organs for transplantation? Hepatology 58:2198-201
Liu, Liping; Yannam, Govardhana Rao; Nishikawa, Taichiro et al. (2012) The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis. Hepatology 55:1529-39
Soto-Gutierrez, Alejandro; Tafaleng, Edgar; Kelly, Victoria et al. (2011) Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come? Hepatology 53:708-11

Showing the most recent 10 out of 37 publications